Cargando…

EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and metastatic breast cancer subtypes lacking targeted therapy. Our recent work demonstrated that circulating tumor cell (CTC) clusters and polyclonal metastasis of TNBC are driven by aggregation of CD44(+) cancer stem cells (CSC) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xia, Adorno-Cruz, Valery, Chang, Ya-Fang, Jia, Yuzhi, Kawaguchi, Madoka, Dashzeveg, Nurmaa K., Taftaf, Rokana, Ramos, Erika K., Schuster, Emma J., El-Shennawy, Lamiaa, Patel, Dhwani, Zhang, Youbin, Cristofanilli, Massimo, Liu, Huiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120216/ https://www.ncbi.nlm.nih.gov/pubmed/33995681 http://dx.doi.org/10.7150/thno.57706

Ejemplares similares

ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer
por: Taftaf, Rokana, et al.
Publicado: (2021)

ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis
por: Adorno-Cruz, Valery, et al.
Publicado: (2020)

Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity
por: Ramos, Erika K, et al.
Publicado: (2022)

Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
por: Dashzeveg, Nurmaa K., et al.
Publicado: (2023)

ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer
por: Li, Dong, et al.
Publicado: (2023)

Better together: circulating tumor cell clustering in metastatic cancer
por: Schuster, Emma, et al.
Publicado: (2021)

Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients
por: Hoffmann, Andrew D., et al.
Publicado: (2023)

Research productivity in Syria: Quantitative and qualitative analysis of current status
por: Diab, Maria M., et al.
Publicado: (2011)

PSAT017 A Case of Aldosterone- and Cortisol Co-secreting Adrenal Corticol Neoplasm with Lipomatous and Myeiolipomatous Metaplasia
por: Jinna, Sruthi, et al.
Publicado: (2022)

Aldosterone- and Cortisol Co-secreting Adrenal Cortical Neoplasm With Lipomatous and Myelolipomatous Metaplasia  
por: Jinna, Sruthi, et al.
Publicado: (2023)

MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells
por: Chen, Wenjing, et al.
Publicado: (2021)

Regulation and functions of integrin α2 in cell adhesion and disease
por: Adorno-Cruz, Valery, et al.
Publicado: (2018)

Evaluation of CO(2) emission from Egypt’s future power plants
por: Abdallah, Lamiaa, et al.
Publicado: (2020)

Benign Metastasizing Leiomyoma: A Rare Type of Lung Metastases—Two Case Reports and Review of the Literature
por: Taftaf, Rokana, et al.
Publicado: (2014)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Mathematical Modelling for the Role of CD4(+)T Cells in Tumor-Immune Interactions
por: Makhlouf, Ahmed M., et al.
Publicado: (2020)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
por: Linklater, Erik S., et al.
Publicado: (2016)

Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy
por: Si, Yingnan, et al.
Publicado: (2020)

The Arabian camel, Camelus dromedarius interferon epsilon: Functional expression, in vitro refolding, purification and cytotoxicity on breast cancer cell lines
por: Abdel-Fattah, Manal, et al.
Publicado: (2019)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
por: Sohn, Joohyuk, et al.
Publicado: (2014)

EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
por: Song, Xiang, et al.
Publicado: (2020)

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
por: Guerrab, Abderrahim El, et al.
Publicado: (2016)

Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
por: El-Shennawy, Lamiaa, et al.
Publicado: (2022)

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer
por: Wang, Zhen, et al.
Publicado: (2021)

Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
por: Imamura, Fumio, et al.
Publicado: (2016)

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
por: Inoue, Satoshi, et al.
Publicado: (2012)

Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer
por: Sood, Neelam, et al.
Publicado: (2014)

Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
por: Hossein-Nejad-Ariani, Hanieh, et al.
Publicado: (2019)

Effects of Annona muricata Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling
por: Alshaeri, Heba K, et al.
Publicado: (2020)

SGLT1 is required for the survival of triple‐negative breast cancer cells via potentiation of EGFR activity
por: Liu, Huiquan, et al.
Publicado: (2019)

Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal cancer cells
por: Napolitano, Stefania, et al.
Publicado: (2017)

High Oxytocin Receptor Expression Linked to Increased Cell Migration and Reduced Survival in Patients with Triple-Negative Breast Cancer
por: Liu, Huiping, et al.
Publicado: (2022)

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
por: Koh, Siang-Boon, et al.
Publicado: (2021)

Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase
por: Thiagarajan, Praveena S., et al.
Publicado: (2018)

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer
por: Brisard, Daphne, et al.
Publicado: (2018)

Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation
por: Nakade, Junya, et al.
Publicado: (2014)

Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer
por: Zoeller, Jason J., et al.
Publicado: (2020)

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
por: Sebastian, Anusha, et al.
Publicado: (2016)

Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells
por: Rosado-Galindo, Heizel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_43err6k3qah0s5llm38ggtm9a1